Natalie Strickland
Pain Medicine · Fort Smith, ARNPI 1275760936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,770 of the $4,256 with a category attached, or 88.6%. 16 manufacturers reported payments, led by Abbott at 34.4% of the total. Reporting peaked in 2023 at $1,086 and has fallen 57.0% since, to $467 in 2025.
Across 164 payments — averaging $25.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Medtronic$973
- Averitas Pharma Inc.$532
- GRT US Holding, Inc.$441
- Boston Scientific$257
- AbbVie$141
- plus $450 from 10 others
What the payments were for
- Travel & lodging$47711%
- Food & beverage$3,77089%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 69 | $1,463 |
| Medtronic(2 entities) | 27 | $973 |
| Averitas Pharma Inc. | 27 | $532 |
| GRT US Holding, Inc. | 14 | $441 |
| Boston Scientific | 4 | $257 |
| AbbVie(2 entities) | 7 | $141 |
| Saluda Medical Americas, Inc. | 5 | $115 |
| Curonix LLC | 1 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $54 |
| Novartis | 1 | $49 |
| Amgen | 2 | $34 |
| Alfasigma USA, Inc. | 2 | $26 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Relievant Medsystems, Inc. | 1 | $19 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$445
- Qutenza$264
- S-Series SCS Leads$133
- Proclaim IPG$110
How this compares
$4,256 in reported general payments places this provider in the 60th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 374 | $4,577 |
| Gabapentin | 361 | $4,352 |
| Nortriptyline Hcl | 224 | $1,956 |
| Methocarbamol | 109 | $1,422 |
| Baclofen | 85 | $672 |
| Pregabalin | 45 | $661 |
| Celecoxib | 36 | $333 |
| Topiramate | 52 | $309 |
| Cyclobenzaprine Hcl | 24 | $215 |
| Oxycodone Hcl | 18 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $183 |
| Tizanidine Hcl | 16 | $175 |
| Tramadol Hcl | 13 | $92 |
| Meloxicam | 36 | $65 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $43 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Fort Smith
- Joseph MillerFort Smith$3K
- John SwicegoodFort Smith$902
- Stephen PaulusLittle Rock$75K
- Mark MiedemaFayetteville$35K
- George ArcosConway$30K
- George DeimelFayetteville$26K
- Julio OlayaLittle Rock$22K
- Maria Lyuksyutova-PriceMountain Home$19K
- Daniel JudkinsConway$17K
- Sheffield KentConway$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.